.9% Ambit Biosciences, Inc. Therapeutics 2013 10.4 11.1 - 11.1 1.06 1.06 13.1% Array Biopharma Inc. Therapeutics 2012 9.0 20.3 - 20.3 2.25 2.25 74.0% Audax Health Solutions, Inc. Convergence 2011 88: 125 1.6 14.1 - 3.68 105.6% Chimerix, Inc. Therapeutics 2011 20.6 27.0 44.9 71.9 3.07 3.50 57.7% Epizyme, Inc. Therapeutics 2013